Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61388963%3A_____%2F19%3A00519586" target="_blank" >RIV/61388963:_____/19:00519586 - isvavai.cz</a>
Result on the web
<a href="https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20190918&DB=&locale=en_EP&CC=EP&NR=3494122B1&KC=B1&ND=4#" target="_blank" >https://worldwide.espacenet.com/publicationDetails/originalDocument?FT=D&date=20190918&DB=&locale=en_EP&CC=EP&NR=3494122B1&KC=B1&ND=4#</a>
DOI - Digital Object Identifier
—
Alternative languages
Result language
angličtina
Original language name
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides for therapeutic use
Original language description
Substituted heteropentadieno-pyrrolopyrimidine ribonucleosides of formula I wherein R is furan-2-yl, furan-3-yl, benzofuran-2-yl, methyl, methylsulfanyl, a methoxy-, amino- or dimethylamino-group and wherein X is an oxygen atom or C1-C5 alkylamino group, or pharmaceutically acceptable salts of such compounds, their optical isomers or a mixture of such optical isomers. The compounds of the invention submitted show strong cytostatic and cytotoxic effects on cell lines of a preferentially tumour origin in a wide variety of diseases, including tumours of a different histogenic origin.
Czech name
—
Czech description
—
Classification
Type
P - Patent
CEP classification
—
OECD FORD branch
30107 - Medicinal chemistry
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2019
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Patent/design ID
EP3494122
Publisher
EPO_1 -
Publisher name
European Patent Office
Place of publication
Munich, The Hague, Berlin, Vienna, Brussels
Publication country
—
Date of acceptance
Sep 18, 2019
Owner name
Ústav organické chemie a biochemie AV ČR, v. v. i. - Univerzita Palackého v Olomouci
Method of use
A - Výsledek využívá pouze poskytovatel
Usage type
A - K využití výsledku jiným subjektem je vždy nutné nabytí licence